≡ Menu

Birth Control Pills Containing Drospirenone: Label Change-Products may be associated with a higher risk for blood clots

A Drug & Medical Device Recall And/Or Safety Alert Has Been Issued: Birth Control Pills Containing Drospirenone: Label Change-Products may be associated with a higher risk for blood clots. According to the Food & Drug Administration FDA’s MedWatch:

Women should talk to their healthcare professional about their risk for blood clots before deciding which birth control method to use.

For more information on the drug or medical device recall or safety alert, read the Food & Drug Administration’s FDA’s drug or medical device recall or safety alert: Birth Control Pills Containing Drospirenone: Label Change-Products may be associated with a higher risk for blood clots.

To report an adverse reaction, problem or other issue with a drug or medical device, submit a drug or medical device complaint to the government at fda.gov or MedWatch.

If you have thoughts on the drug or medical device recall or safety alert, share your drug or medical device recall or safety alert comments below.

{ 0 comments… add one }

Leave a Comment